Sandbox:ap: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:


== Differential diagnosis ==
== Differential diagnosis ==
{| class="wikitable"
{|
! colspan="4" |Hypoparathyroidism
! colspan="4" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Hypoparathyroidism}}
!Inheritance
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Inheritance}}
!Gene mutation
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Gene mutation}}
!Clinical features
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Clinical features}}
|-
|-
| colspan="2" |Autoimmune<ref name="pmid2348835">{{cite journal |vauthors=Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J |title=Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients |journal=N. Engl. J. Med. |volume=322 |issue=26 |pages=1829–36 |year=1990 |pmid=2348835 |doi=10.1056/NEJM199006283222601 |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autoimmune<ref name="pmid2348835">{{cite journal |vauthors=Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J |title=Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients |journal=N. Engl. J. Med. |volume=322 |issue=26 |pages=1829–36 |year=1990 |pmid=2348835 |doi=10.1056/NEJM199006283222601 |url=}}</ref>
| Autoimmune polyglandular hypoparathyroidism
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autoimmune polyglandular hypoparathyroidism
| Autoimmune polyglandular endocrinopathy type 1
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autoimmune polyglandular endocrinopathy type 1
| [[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| Mutation in AIRE gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation in AIRE gene
|
| style="padding: 5px 5px; background: #F5F5F5;" |
*Also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
*Also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
*Presents with a variable combination of:
*Presents with a variable combination of:
Line 34: Line 34:
**Dystrophy of dental enamel and nails, alopecia, vitiligo, and keratopath
**Dystrophy of dental enamel and nails, alopecia, vitiligo, and keratopath
|-
|-
| colspan="2" rowspan="7" |Isolated
| colspan="2" rowspan="7"  style="padding: 5px 5px; background: #DCDCDC;" align="center" |Isolated
| colspan="2" rowspan="5" |Familial Isolated hypoparathyroidism
| colspan="2" rowspan="5"  style="padding: 5px 5px; background: #DCDCDC;" align="center" |Familial Isolated hypoparathyroidism
| rowspan="2" |[[Autosomal dominant]]
| rowspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
|PTH gene<ref name="pmid2212001">{{cite journal |vauthors=Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM |title=Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism |journal=J. Clin. Invest. |volume=86 |issue=4 |pages=1084–7 |year=1990 |pmid=2212001 |pmc=296835 |doi=10.1172/JCI114811 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene<ref name="pmid2212001">{{cite journal |vauthors=Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM |title=Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism |journal=J. Clin. Invest. |volume=86 |issue=4 |pages=1084–7 |year=1990 |pmid=2212001 |pmc=296835 |doi=10.1172/JCI114811 |url=}}</ref>
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Clinical features of hypocalcemia including
*Clinical features of hypocalcemia including
**Tetany (hallmark of acute hypocalcemia)
**Tetany (hallmark of acute hypocalcemia)
Line 45: Line 45:
**Circumoral numbness
**Circumoral numbness
|-
|-
|[[GCM2]] gene<ref name="pmid18712808">{{cite journal |vauthors=Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN |title=Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism |journal=Hum. Mutat. |volume=30 |issue=1 |pages=85–92 |year=2009 |pmid=18712808 |doi=10.1002/humu.20827 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[GCM2]] gene<ref name="pmid18712808">{{cite journal |vauthors=Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN |title=Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism |journal=Hum. Mutat. |volume=30 |issue=1 |pages=85–92 |year=2009 |pmid=18712808 |doi=10.1002/humu.20827 |url=}}</ref>
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Clinical features of hypocalcemia including
*Clinical features of hypocalcemia including
**Tetany (hallmark of acute hypocalcemia)
**Tetany (hallmark of acute hypocalcemia)
Line 54: Line 54:
*[[Dominant negative mutation]]
*[[Dominant negative mutation]]
|-
|-
| rowspan="2" |[[Autosomal recessive]]
| rowspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
|PTH gene<ref name="pmid10523031">{{cite journal |vauthors=Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S |title=A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism |journal=J. Clin. Endocrinol. Metab. |volume=84 |issue=10 |pages=3792–6 |year=1999 |pmid=10523031 |doi=10.1210/jcem.84.10.6070 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene<ref name="pmid10523031">{{cite journal |vauthors=Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S |title=A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism |journal=J. Clin. Endocrinol. Metab. |volume=84 |issue=10 |pages=3792–6 |year=1999 |pmid=10523031 |doi=10.1210/jcem.84.10.6070 |url=}}</ref>
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Clinical features of hypocalcemia including
*Clinical features of hypocalcemia including
**Tetany (hallmark of acute hypocalcemia)
**Tetany (hallmark of acute hypocalcemia)
Line 63: Line 63:
**Circumoral numbness
**Circumoral numbness
|-
|-
|[[GCM2]] gene<ref name="pmid18712808" /><ref name="pmid11602629">{{cite journal |vauthors=Ding C, Buckingham B, Levine MA |title=Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB |journal=J. Clin. Invest. |volume=108 |issue=8 |pages=1215–20 |year=2001 |pmid=11602629 |pmc=209530 |doi=10.1172/JCI13180 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[GCM2]] gene<ref name="pmid18712808" /><ref name="pmid11602629">{{cite journal |vauthors=Ding C, Buckingham B, Levine MA |title=Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB |journal=J. Clin. Invest. |volume=108 |issue=8 |pages=1215–20 |year=2001 |pmid=11602629 |pmc=209530 |doi=10.1172/JCI13180 |url=}}</ref>
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Clinical features of hypocalcemia including
*Clinical features of hypocalcemia including
**Tetany (hallmark of acute hypocalcemia)
**Tetany (hallmark of acute hypocalcemia)
Line 71: Line 71:
**Circumoral numbness
**Circumoral numbness
|-
|-
|[[X-linked]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[X-linked]]
|[[FHL1 (gene)|FHL1]] gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.<ref name="pmid28444561">{{cite journal |vauthors=Pillar N, Pleniceanu O, Fang M, Ziv L, Lahav E, Botchan S, Cheng L, Dekel B, Shomron N |title=A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism |journal=Hum. Genet. |volume=136 |issue=7 |pages=835–845 |year=2017 |pmid=28444561 |pmc=5487855 |doi=10.1007/s00439-017-1804-9 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FHL1 (gene)|FHL1]] gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.<ref name="pmid28444561">{{cite journal |vauthors=Pillar N, Pleniceanu O, Fang M, Ziv L, Lahav E, Botchan S, Cheng L, Dekel B, Shomron N |title=A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism |journal=Hum. Genet. |volume=136 |issue=7 |pages=835–845 |year=2017 |pmid=28444561 |pmc=5487855 |doi=10.1007/s00439-017-1804-9 |url=}}</ref>
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Clinical features of hypocalcemia including
*Clinical features of hypocalcemia including
**Tetany (hallmark of acute hypocalcemia)
**Tetany (hallmark of acute hypocalcemia)
Line 80: Line 80:
**Circumoral numbness
**Circumoral numbness
|-
|-
| rowspan="2" |Autosomal dominant hypercalcemia<ref name="pmid278036722">{{cite journal |vauthors=Roszko KL, Bi RD, Mannstadt M |title=Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2 |journal=Front Physiol |volume=7 |issue= |pages=458 |year=2016 |pmid=27803672 |pmc=5067375 |doi=10.3389/fphys.2016.00458 |url=}}</ref>
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypercalcemia<ref name="pmid278036722">{{cite journal |vauthors=Roszko KL, Bi RD, Mannstadt M |title=Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2 |journal=Front Physiol |volume=7 |issue= |pages=458 |year=2016 |pmid=27803672 |pmc=5067375 |doi=10.3389/fphys.2016.00458 |url=}}</ref>
|Autosomal dominant hypocalcemia type 1
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 1
|[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
|Calcium-sensing receptor gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Calcium-sensing receptor gene mutation
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*[[Calcium-sensing receptor|Calcium-sensing]] receptor gene activating mutation.
*[[Calcium-sensing receptor|Calcium-sensing]] receptor gene activating mutation.
*'''Most common genetic form''' of hypoparathyroidism.
*'''Most common genetic form''' of hypoparathyroidism.
Line 91: Line 91:
*Calcium-sensing receptor gene activating mutation can also cause Bartter syndrome type 5.This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.<ref name="pmid17048213">{{cite journal |vauthors=Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L |title=Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome |journal=J. Nephrol. |volume=19 |issue=4 |pages=525–8 |year=2006 |pmid=17048213 |doi= |url=}}</ref><ref name="pmid25932037">{{cite journal |vauthors=Choi KH, Shin CH, Yang SW, Cheong HI |title=Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C |journal=Korean J Pediatr |volume=58 |issue=4 |pages=148–53 |year=2015 |pmid=25932037 |pmc=4414630 |doi=10.3345/kjp.2015.58.4.148 |url=}}</ref>
*Calcium-sensing receptor gene activating mutation can also cause Bartter syndrome type 5.This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.<ref name="pmid17048213">{{cite journal |vauthors=Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L |title=Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome |journal=J. Nephrol. |volume=19 |issue=4 |pages=525–8 |year=2006 |pmid=17048213 |doi= |url=}}</ref><ref name="pmid25932037">{{cite journal |vauthors=Choi KH, Shin CH, Yang SW, Cheong HI |title=Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C |journal=Korean J Pediatr |volume=58 |issue=4 |pages=148–53 |year=2015 |pmid=25932037 |pmc=4414630 |doi=10.3345/kjp.2015.58.4.148 |url=}}</ref>
|-
|-
|Autosomal dominant hypocalcemia type 2
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 2
|[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
|G protein G11 (GNA11) mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G protein G11 (GNA11) mutation
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Clinical features of hypocalcemia including
*Clinical features of hypocalcemia including
**Tetany (hallmark of acute hypocalcemia)
**Tetany (hallmark of acute hypocalcemia)
Line 101: Line 101:
**Circumoral numbness
**Circumoral numbness
|-
|-
| colspan="2" rowspan="6" |Congenital multisystem syndromes
| colspan="2" rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Congenital multisystem syndromes
| colspan="2" |'''[[DiGeorge syndrome]]'''<ref name="pmid21049214">{{cite journal |vauthors=Fomin AB, Pastorino AC, Kim CA, Pereira CA, Carneiro-Sampaio M, Abe-Jacob CM |title=DiGeorge Syndrome: a not so rare disease |journal=Clinics (Sao Paulo) |volume=65 |issue=9 |pages=865–9 |year=2010 |pmid=21049214 |pmc=2954737 |doi= |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[DiGeorge syndrome]]'''<ref name="pmid21049214">{{cite journal |vauthors=Fomin AB, Pastorino AC, Kim CA, Pereira CA, Carneiro-Sampaio M, Abe-Jacob CM |title=DiGeorge Syndrome: a not so rare disease |journal=Clinics (Sao Paulo) |volume=65 |issue=9 |pages=865–9 |year=2010 |pmid=21049214 |pmc=2954737 |doi= |url=}}</ref>
|[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
|[[22q11.2 deletion syndrome|22q11.2 deletion]].
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[22q11.2 deletion syndrome|22q11.2 deletion]].
|
| style="padding: 5px 5px; background: #F5F5F5;" |
* Presents with [[thymus]] [[dysfunction]], [[cardiac]] defects, [[immunodeficiency]], [[hypocalcemia]], and other clinical problems.
* Presents with [[thymus]] [[dysfunction]], [[cardiac]] defects, [[immunodeficiency]], [[hypocalcemia]], and other clinical problems.
*Also known as [[22q11.2DS]], [[CATCH 22 syndrome]], [[Cayler cardiofacial syndrome]], [[conotruncal anomaly face syndrome]] ([[CTAF]]), [[deletion 22q11.2 syndrome]], [[Sedlackova syndrome]], [[Shprintzen syndrome]], VCFS, [[velocardiofacial syndrome]], and velo-cardio-facial syndrome.
*Also known as [[22q11.2DS]], [[CATCH 22 syndrome]], [[Cayler cardiofacial syndrome]], [[conotruncal anomaly face syndrome]] ([[CTAF]]), [[deletion 22q11.2 syndrome]], [[Sedlackova syndrome]], [[Shprintzen syndrome]], VCFS, [[velocardiofacial syndrome]], and velo-cardio-facial syndrome.
*[[CATCH 22 syndrome|CATCH 22]] stands for [[cardiac]] defects, abnormal facies, [[thymic]] [[aplasia]], [[cleft palate]], and [[hypocalcemia]] with [[22q11.2 deletion syndrome|22q11.2 deletion]].
*[[CATCH 22 syndrome|CATCH 22]] stands for [[cardiac]] defects, abnormal facies, [[thymic]] [[aplasia]], [[cleft palate]], and [[hypocalcemia]] with [[22q11.2 deletion syndrome|22q11.2 deletion]].
|-
|-
| colspan="2" |'''[[CHARGE syndrome]]'''<ref name="pmid21995344">{{cite journal |vauthors=Jain S, Kim HG, Lacbawan F, Meliciani I, Wenzel W, Kurth I, Sharma J, Schoeneman M, Ten S, Layman LC, Jacobson-Dickman E |title=Unique phenotype in a patient with CHARGE syndrome |journal=Int J Pediatr Endocrinol |volume=2011 |issue= |pages=11 |year=2011 |pmid=21995344 |pmc=3216247 |doi=10.1186/1687-9856-2011-11 |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[CHARGE syndrome]]'''<ref name="pmid21995344">{{cite journal |vauthors=Jain S, Kim HG, Lacbawan F, Meliciani I, Wenzel W, Kurth I, Sharma J, Schoeneman M, Ten S, Layman LC, Jacobson-Dickman E |title=Unique phenotype in a patient with CHARGE syndrome |journal=Int J Pediatr Endocrinol |volume=2011 |issue= |pages=11 |year=2011 |pmid=21995344 |pmc=3216247 |doi=10.1186/1687-9856-2011-11 |url=}}</ref>
|[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
|CHD7 G744S [[missense mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CHD7 G744S [[missense mutation]]
|
| style="padding: 5px 5px; background: #F5F5F5;"|
* Presents with [[coloboma]], [[heart]] defects, [[Choanal atresia|atresia choanae]], retarded growth and development, [[Genitourinary pathology|genitourinary abnormalities]], and [[ear]] anomalies and/or [[deafness]].
* Presents with [[coloboma]], [[heart]] defects, [[Choanal atresia|atresia choanae]], retarded growth and development, [[Genitourinary pathology|genitourinary abnormalities]], and [[ear]] anomalies and/or [[deafness]].
|-
|-
| colspan="2" |'''Kenny-Caffey syndrome type 1'''<ref name="pmid23087875">{{cite journal |vauthors=Metwalley KA, Farghaly HS |title=Kenny-Caffey syndrome type 1 in an Egyptian girl |journal=Indian J Endocrinol Metab |volume=16 |issue=5 |pages=827–9 |year=2012 |pmid=23087875 |pmc=3475915 |doi=10.4103/2230-8210.100645 |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Kenny-Caffey syndrome type 1'''<ref name="pmid23087875">{{cite journal |vauthors=Metwalley KA, Farghaly HS |title=Kenny-Caffey syndrome type 1 in an Egyptian girl |journal=Indian J Endocrinol Metab |volume=16 |issue=5 |pages=827–9 |year=2012 |pmid=23087875 |pmc=3475915 |doi=10.4103/2230-8210.100645 |url=}}</ref>
|[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
|Deletion of the [[TBCE]] gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Deletion of the [[TBCE]] gene
|
| style="padding: 5px 5px; background: #F5F5F5;"|
* Presents with [[hypoparathyroidism]] due to absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones.
* Presents with [[hypoparathyroidism]] due to absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones.
|-
|-
| colspan="2" |'''Kenny-Caffey syndrome type 2'''<ref name="pmid23996431">{{cite journal |vauthors=Isojima T, Doi K, Mitsui J, Oda Y, Tokuhiro E, Yasoda A, Yorifuji T, Horikawa R, Yoshimura J, Ishiura H, Morishita S, Tsuji S, Kitanaka S |title=A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2 |journal=J. Bone Miner. Res. |volume=29 |issue=4 |pages=992–8 |year=2014 |pmid=23996431 |doi=10.1002/jbmr.2091 |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Kenny-Caffey syndrome type 2'''<ref name="pmid23996431">{{cite journal |vauthors=Isojima T, Doi K, Mitsui J, Oda Y, Tokuhiro E, Yasoda A, Yorifuji T, Horikawa R, Yoshimura J, Ishiura H, Morishita S, Tsuji S, Kitanaka S |title=A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2 |journal=J. Bone Miner. Res. |volume=29 |issue=4 |pages=992–8 |year=2014 |pmid=23996431 |doi=10.1002/jbmr.2091 |url=}}</ref>
|[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
|Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
|
| style="padding: 5px 5px; background: #F5F5F5;"|
* Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for mental retardation.
* Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for mental retardation.
|-
|-
| colspan="2" |'''Sanjad-Sakati syndrome'''<ref name="pmid22043344">{{cite journal |vauthors=Rafique B, Al-Yaarubi S |title=Sanjad-Sakati Syndrome in Omani children |journal=Oman Med J |volume=25 |issue=3 |pages=227–9 |year=2010 |pmid=22043344 |pmc=3191633 |doi=10.5001/omj.2010.63 |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Sanjad-Sakati syndrome'''<ref name="pmid22043344">{{cite journal |vauthors=Rafique B, Al-Yaarubi S |title=Sanjad-Sakati Syndrome in Omani children |journal=Oman Med J |volume=25 |issue=3 |pages=227–9 |year=2010 |pmid=22043344 |pmc=3191633 |doi=10.5001/omj.2010.63 |url=}}</ref>
|[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
|Mutation in [[TBCE]] gene.
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation in [[TBCE]] gene.
|
| style="padding: 5px 5px; background: #F5F5F5;"|
* Sanjad-Sakati syndrome in exclusively found in arabian descent population.
* Sanjad-Sakati syndrome in exclusively found in arabian descent population.
* Presents with hypoparathyroidism, [[intellectual disability]], [[Dysmorphic feature|dysmorphism]].
* Presents with hypoparathyroidism, [[intellectual disability]], [[Dysmorphic feature|dysmorphism]].
|-
|-
| colspan="2" |'''[[Barakat syndrome]]'''<ref name="pmid11389161">{{cite journal |vauthors=Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T |title=GATA3 abnormalities and the phenotypic spectrum of HDR syndrome |journal=J. Med. Genet. |volume=38 |issue=6 |pages=374–80 |year=2001 |pmid=11389161 |pmc=1734904 |doi= |url=}}</ref><ref name="pmid10935639">{{cite journal |vauthors=Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K |title=GATA3 haplo-insufficiency causes human HDR syndrome |journal=Nature |volume=406 |issue=6794 |pages=419–22 |year=2000 |pmid=10935639 |doi=10.1038/35019088 |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[Barakat syndrome]]'''<ref name="pmid11389161">{{cite journal |vauthors=Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T |title=GATA3 abnormalities and the phenotypic spectrum of HDR syndrome |journal=J. Med. Genet. |volume=38 |issue=6 |pages=374–80 |year=2001 |pmid=11389161 |pmc=1734904 |doi= |url=}}</ref><ref name="pmid10935639">{{cite journal |vauthors=Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K |title=GATA3 haplo-insufficiency causes human HDR syndrome |journal=Nature |volume=406 |issue=6794 |pages=419–22 |year=2000 |pmid=10935639 |doi=10.1038/35019088 |url=}}</ref>
|[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
|[[Mutation|Mutations]] in the [[GATA3]] gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mutation|Mutations]] in the [[GATA3]] gene
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Also known as hypoparathyroidism, [[deafness]], and renal dysplasia (HDR) syndrome
*Also known as hypoparathyroidism, [[deafness]], and renal dysplasia (HDR) syndrome
*Presents with primary hypoparathyroidism, nerve [[deafness]], steroid-resistant [[nephrosis]].
*Presents with primary hypoparathyroidism, nerve [[deafness]], steroid-resistant [[nephrosis]].
|-
|-
| rowspan="6" |Metabolic diseases
| rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Metabolic diseases
| rowspan="2" |Mitochondiral polyneuropathies<ref name="pmid27716753">{{cite journal |vauthors=Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S |title=Mitochondrial disease and endocrine dysfunction |journal=Nat Rev Endocrinol |volume=13 |issue=2 |pages=92–104 |year=2017 |pmid=27716753 |doi=10.1038/nrendo.2016.151 |url=}}</ref>
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Mitochondiral polyneuropathies<ref name="pmid27716753">{{cite journal |vauthors=Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S |title=Mitochondrial disease and endocrine dysfunction |journal=Nat Rev Endocrinol |volume=13 |issue=2 |pages=92–104 |year=2017 |pmid=27716753 |doi=10.1038/nrendo.2016.151 |url=}}</ref>
| colspan="2" |Kearns–Sayre syndrome
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Kearns–Sayre syndrome
| Mitochondrial inheritence
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Mitochondrial inheritence
| mtDNA deletion
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | mtDNA deletion
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Progressive external ophthalmoplegia
*Progressive external ophthalmoplegia
*Retinitis pigmentosa
*Retinitis pigmentosa
Line 154: Line 153:
*Heart block
*Heart block
|-
|-
| colspan="2" |Maternally inherited diabetes and deafness (MIDD)
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Maternally inherited diabetes and deafness (MIDD)
| Mitochondrial inheritence
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Mitochondrial inheritence
| MT‑TL1
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | MT‑TL1
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Diabetes mellitus and deafness
*Diabetes mellitus and deafness
|-
|-
| rowspan="2" |Mitochondrial enzyme deficiencies
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Mitochondrial enzyme deficiencies
| colspan="2" |Mitochondrial trifunctional protein deficiency (MTP deficiency)<ref name="pmid16523289">{{cite journal |vauthors=Labarthe F, Benoist JF, Brivet M, Vianey-Saban C, Despert F, de Baulny HO |title=Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency |journal=Eur. J. Pediatr. |volume=165 |issue=6 |pages=389–91 |year=2006 |pmid=16523289 |doi=10.1007/s00431-005-0052-5 |url=}}</ref><ref name="urlmitochondrial trifunctional protein deficiency - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/mitochondrial-trifunctional-protein-deficiency |title=mitochondrial trifunctional protein deficiency - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Mitochondrial trifunctional protein deficiency (MTP deficiency)<ref name="pmid16523289">{{cite journal |vauthors=Labarthe F, Benoist JF, Brivet M, Vianey-Saban C, Despert F, de Baulny HO |title=Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency |journal=Eur. J. Pediatr. |volume=165 |issue=6 |pages=389–91 |year=2006 |pmid=16523289 |doi=10.1007/s00431-005-0052-5 |url=}}</ref><ref name="urlmitochondrial trifunctional protein deficiency - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/mitochondrial-trifunctional-protein-deficiency |title=mitochondrial trifunctional protein deficiency - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| [[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[Autosomal recessive]]
| HADHA or HADHB gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | HADHA or HADHB gene mutation
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include feeding difficulties, lethargy, hypoglycemia, hypotonia, and liver problems.
*Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include feeding difficulties, lethargy, hypoglycemia, hypotonia, and liver problems.
*Infants with mitochondrial trifunctional protein deficiency are also at high risk for serious heart problems, breathing difficulties, coma, and sudden death.
*Infants with mitochondrial trifunctional protein deficiency are also at high risk for serious heart problems, breathing difficulties, coma, and sudden death.
*Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include hypotonia, muscle pain, a breakdown of muscle tissue, and a loss of sensation in the extremities (peripheral neuropathy).
*Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include hypotonia, muscle pain, a breakdown of muscle tissue, and a loss of sensation in the extremities (peripheral neuropathy).
|-
|-
| colspan="2" |Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)<ref name="pmid9403664">{{cite journal |vauthors=Tyni T, Rapola J, Palotie A, Pihko H |title=Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation |journal=J. Pediatr. |volume=131 |issue=5 |pages=766–8 |year=1997 |pmid=9403664 |doi= |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)<ref name="pmid9403664">{{cite journal |vauthors=Tyni T, Rapola J, Palotie A, Pihko H |title=Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation |journal=J. Pediatr. |volume=131 |issue=5 |pages=766–8 |year=1997 |pmid=9403664 |doi= |url=}}</ref>
| [[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| G1528C gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G1528C gene mutation
|
| style="padding: 5px 5px; background: #F5F5F5;"|
* Hypoglycemia
* Hypoglycemia
*Hepatopathy
*Hepatopathy
Line 179: Line 178:
*Retinopathy
*Retinopathy
|-
|-
| rowspan="2" |Heavy metal storage disorders
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Heavy metal storage disorders
| colspan="2" |Hemochromatosis<ref name="pmid24741460">{{cite journal |vauthors=Jeong HK, An JH, Kim HS, Cho EA, Han MG, Moon JS, Kim HK, Kang HC |title=Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis |journal=Endocrinol Metab (Seoul) |volume=29 |issue=1 |pages=91–5 |year=2014 |pmid=24741460 |pmc=3970271 |doi=10.3803/EnM.2014.29.1.91 |url=}}</ref><ref name="urlhereditary hemochromatosis - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/hereditary-hemochromatosis |title=hereditary hemochromatosis - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hemochromatosis<ref name="pmid24741460">{{cite journal |vauthors=Jeong HK, An JH, Kim HS, Cho EA, Han MG, Moon JS, Kim HK, Kang HC |title=Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis |journal=Endocrinol Metab (Seoul) |volume=29 |issue=1 |pages=91–5 |year=2014 |pmid=24741460 |pmc=3970271 |doi=10.3803/EnM.2014.29.1.91 |url=}}</ref><ref name="urlhereditary hemochromatosis - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/hereditary-hemochromatosis |title=hereditary hemochromatosis - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| [[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| HFE gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |HFE gene mutation
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Early symptoms of hereditary hemochromatosis are nonspecific and may include fatigue, joint pain, abdominal pain, and loss of sex drive.
*Early symptoms of hereditary hemochromatosis are nonspecific and may include fatigue, joint pain, abdominal pain, and loss of sex drive.
*Late stage clinical fearures may include arthritis, liver disease, diabetes, heart abnormalities, and skin discoloration.  
*Late stage clinical fearures may include arthritis, liver disease, diabetes, heart abnormalities, and skin discoloration.  
|-
|-
| colspan="2" |Wilson's disease<ref name="pmid6888480">{{cite journal |vauthors=Carpenter TO, Carnes DL, Anast CS |title=Hypoparathyroidism in Wilson's disease |journal=N. Engl. J. Med. |volume=309 |issue=15 |pages=873–7 |year=1983 |pmid=6888480 |doi=10.1056/NEJM198310133091501 |url=}}</ref><ref name="urlWilson disease - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/wilson-disease#definition |title=Wilson disease - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Wilson's disease<ref name="pmid6888480">{{cite journal |vauthors=Carpenter TO, Carnes DL, Anast CS |title=Hypoparathyroidism in Wilson's disease |journal=N. Engl. J. Med. |volume=309 |issue=15 |pages=873–7 |year=1983 |pmid=6888480 |doi=10.1056/NEJM198310133091501 |url=}}</ref><ref name="urlWilson disease - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/wilson-disease#definition |title=Wilson disease - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| [[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[Autosomal recessive]]
| ATP7B gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ATP7B gene mutation
|
| style="padding: 5px 5px; background: #F5F5F5;"|
*Initial features include liver disease in children and young adults.
*Initial features include liver disease in children and young adults.
*Initial features include nervous systems and psychiatric problems in adults.
*Initial features include nervous systems and psychiatric problems in adults.

Revision as of 20:55, 29 September 2017

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypercalcemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Related to Parathyroid gland
 
 
 
 
 
 
 
 
 
 
 
Unrelated to parathyroid gland
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary hyperparathyroidism
 
 
Secondary hyperparathyroidism
 
 
Tertiary hyperparathyroidism
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Typical primary hyperparathyroidism
 
Familial hypocalciuric hypercalcemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Malignancy
 
 
 
 
 
Medication induced
 
 
 
Nutritional
 
 
 
 
Granulomatous disease
 
 
Surgical
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Para-neoplastic syndrome: Parathyroid hormone related peptide
 
Metaplasia: Hypercalcemia due to bone destruction
 
Thiazide diuretics
 
Lithium
 
Milk alkali syndrome
 
Vitamin D toxicity
 
Sarcoidosis
 
 
Immobilization
 

Differential diagnosis

Hypoparathyroidism Inheritance Gene mutation Clinical features
Autoimmune[1] Autoimmune polyglandular hypoparathyroidism Autoimmune polyglandular endocrinopathy type 1 Autosomal recessive Mutation in AIRE gene
  • Also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
  • Presents with a variable combination of:
    • Failure of the parathyroid glands, adrenal cortex, gonads, pancreatic beta cells, gastric parietal cells, and thyroid gland, and hepatitis
    • Chronic mucocutaneous candidiasis
    • Dystrophy of dental enamel and nails, alopecia, vitiligo, and keratopath
Isolated Familial Isolated hypoparathyroidism Autosomal dominant PTH gene[2]
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
GCM2 gene[3]
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
  • Dominant negative mutation
Autosomal recessive PTH gene[4]
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
GCM2 gene[3][5]
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
X-linked FHL1 gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.[6]
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
Autosomal dominant hypercalcemia[7] Autosomal dominant hypocalcemia type 1 Autosomal dominant Calcium-sensing receptor gene mutation
  • Calcium-sensing receptor gene activating mutation.
  • Most common genetic form of hypoparathyroidism.
  • Also known as familial hypercalciuric hypocalcemia.
  • The activating mutation results in gain in function.
  • Calcium-sensing receptor gene activating mutation can also cause Bartter syndrome type 5.This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.[8][9]
Autosomal dominant hypocalcemia type 2 Autosomal dominant G protein G11 (GNA11) mutation
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
Congenital multisystem syndromes DiGeorge syndrome[10] Autosomal dominant 22q11.2 deletion.
CHARGE syndrome[11] Autosomal dominant CHD7 G744S missense mutation
Kenny-Caffey syndrome type 1[12] Autosomal recessive Deletion of the TBCE gene
  • Presents with hypoparathyroidism due to absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones.
Kenny-Caffey syndrome type 2[13] Autosomal dominant Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
  • Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for mental retardation.
Sanjad-Sakati syndrome[14] Autosomal recessive Mutation in TBCE gene.
Barakat syndrome[15][16] Autosomal recessive Mutations in the GATA3 gene
  • Also known as hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome
  • Presents with primary hypoparathyroidism, nerve deafness, steroid-resistant nephrosis.
Metabolic diseases Mitochondiral polyneuropathies[17] Kearns–Sayre syndrome Mitochondrial inheritence mtDNA deletion
  • Progressive external ophthalmoplegia
  • Retinitis pigmentosa
  • Cardiomyopathy,
  • Heart block
Maternally inherited diabetes and deafness (MIDD) Mitochondrial inheritence MT‑TL1
  • Diabetes mellitus and deafness
Mitochondrial enzyme deficiencies Mitochondrial trifunctional protein deficiency (MTP deficiency)[18][19] Autosomal recessive HADHA or HADHB gene mutation
  • Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include feeding difficulties, lethargy, hypoglycemia, hypotonia, and liver problems.
  • Infants with mitochondrial trifunctional protein deficiency are also at high risk for serious heart problems, breathing difficulties, coma, and sudden death.
  • Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include hypotonia, muscle pain, a breakdown of muscle tissue, and a loss of sensation in the extremities (peripheral neuropathy).
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)[20] Autosomal recessive G1528C gene mutation
  • Hypoglycemia
  • Hepatopathy
  • Hypotonia
  • Cardiomyopathy
  • Retinopathy
Heavy metal storage disorders Hemochromatosis[21][22] Autosomal recessive HFE gene mutation
  • Early symptoms of hereditary hemochromatosis are nonspecific and may include fatigue, joint pain, abdominal pain, and loss of sex drive.
  • Late stage clinical fearures may include arthritis, liver disease, diabetes, heart abnormalities, and skin discoloration.
Wilson's disease[23][24] Autosomal recessive ATP7B gene mutation
  • Initial features include liver disease in children and young adults.
  • Initial features include nervous systems and psychiatric problems in adults.
  • Other clinical features include clumsiness, tremors, difficulty walking, speech problems, impaired thinking ability, depression, anxiety, and mood swings.
  1. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J (1990). "Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients". N. Engl. J. Med. 322 (26): 1829–36. doi:10.1056/NEJM199006283222601. PMID 2348835.
  2. Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990). "Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism". J. Clin. Invest. 86 (4): 1084–7. doi:10.1172/JCI114811. PMC 296835. PMID 2212001.
  3. 3.0 3.1 Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN (2009). "Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism". Hum. Mutat. 30 (1): 85–92. doi:10.1002/humu.20827. PMID 18712808.
  4. Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S (1999). "A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism". J. Clin. Endocrinol. Metab. 84 (10): 3792–6. doi:10.1210/jcem.84.10.6070. PMID 10523031.
  5. Ding C, Buckingham B, Levine MA (2001). "Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB". J. Clin. Invest. 108 (8): 1215–20. doi:10.1172/JCI13180. PMC 209530. PMID 11602629.
  6. Pillar N, Pleniceanu O, Fang M, Ziv L, Lahav E, Botchan S, Cheng L, Dekel B, Shomron N (2017). "A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism". Hum. Genet. 136 (7): 835–845. doi:10.1007/s00439-017-1804-9. PMC 5487855. PMID 28444561.
  7. Roszko KL, Bi RD, Mannstadt M (2016). "Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2". Front Physiol. 7: 458. doi:10.3389/fphys.2016.00458. PMC 5067375. PMID 27803672.
  8. Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L (2006). "Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome". J. Nephrol. 19 (4): 525–8. PMID 17048213.
  9. Choi KH, Shin CH, Yang SW, Cheong HI (2015). "Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C". Korean J Pediatr. 58 (4): 148–53. doi:10.3345/kjp.2015.58.4.148. PMC 4414630. PMID 25932037.
  10. Fomin AB, Pastorino AC, Kim CA, Pereira CA, Carneiro-Sampaio M, Abe-Jacob CM (2010). "DiGeorge Syndrome: a not so rare disease". Clinics (Sao Paulo). 65 (9): 865–9. PMC 2954737. PMID 21049214.
  11. Jain S, Kim HG, Lacbawan F, Meliciani I, Wenzel W, Kurth I, Sharma J, Schoeneman M, Ten S, Layman LC, Jacobson-Dickman E (2011). "Unique phenotype in a patient with CHARGE syndrome". Int J Pediatr Endocrinol. 2011: 11. doi:10.1186/1687-9856-2011-11. PMC 3216247. PMID 21995344.
  12. Metwalley KA, Farghaly HS (2012). "Kenny-Caffey syndrome type 1 in an Egyptian girl". Indian J Endocrinol Metab. 16 (5): 827–9. doi:10.4103/2230-8210.100645. PMC 3475915. PMID 23087875.
  13. Isojima T, Doi K, Mitsui J, Oda Y, Tokuhiro E, Yasoda A, Yorifuji T, Horikawa R, Yoshimura J, Ishiura H, Morishita S, Tsuji S, Kitanaka S (2014). "A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2". J. Bone Miner. Res. 29 (4): 992–8. doi:10.1002/jbmr.2091. PMID 23996431.
  14. Rafique B, Al-Yaarubi S (2010). "Sanjad-Sakati Syndrome in Omani children". Oman Med J. 25 (3): 227–9. doi:10.5001/omj.2010.63. PMC 3191633. PMID 22043344.
  15. Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T (2001). "GATA3 abnormalities and the phenotypic spectrum of HDR syndrome". J. Med. Genet. 38 (6): 374–80. PMC 1734904. PMID 11389161.
  16. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K (2000). "GATA3 haplo-insufficiency causes human HDR syndrome". Nature. 406 (6794): 419–22. doi:10.1038/35019088. PMID 10935639.
  17. Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S (2017). "Mitochondrial disease and endocrine dysfunction". Nat Rev Endocrinol. 13 (2): 92–104. doi:10.1038/nrendo.2016.151. PMID 27716753.
  18. Labarthe F, Benoist JF, Brivet M, Vianey-Saban C, Despert F, de Baulny HO (2006). "Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency". Eur. J. Pediatr. 165 (6): 389–91. doi:10.1007/s00431-005-0052-5. PMID 16523289.
  19. "mitochondrial trifunctional protein deficiency - Genetics Home Reference".
  20. Tyni T, Rapola J, Palotie A, Pihko H (1997). "Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation". J. Pediatr. 131 (5): 766–8. PMID 9403664.
  21. Jeong HK, An JH, Kim HS, Cho EA, Han MG, Moon JS, Kim HK, Kang HC (2014). "Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis". Endocrinol Metab (Seoul). 29 (1): 91–5. doi:10.3803/EnM.2014.29.1.91. PMC 3970271. PMID 24741460.
  22. "hereditary hemochromatosis - Genetics Home Reference".
  23. Carpenter TO, Carnes DL, Anast CS (1983). "Hypoparathyroidism in Wilson's disease". N. Engl. J. Med. 309 (15): 873–7. doi:10.1056/NEJM198310133091501. PMID 6888480.
  24. "Wilson disease - Genetics Home Reference".